Paul Mintz

CIK: 0001480208

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (57.1%)

Derivative conversions

Awards (A)1 (14.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AURX

Nuo Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

AURX
Nuo Therapeutics, Inc.
Jun 29, 2026
Award(A)
Option to Purchase Common Stock
Direct
30K shares-
AURX
Nuo Therapeutics, Inc.
Dec 9, 2025
Exercise(M)
Direct
50K shares at avg. $0.40$20K
AURX
Nuo Therapeutics, Inc.
Dec 9, 2025
Tax Payment(F)
Direct
9.1K shares at avg. $2.20$20K
AURX
Nuo Therapeutics, Inc.
Aug 1, 2025
Exercise(M)
Direct
87.5K shares at avg. $0.40$35K
AURX
Nuo Therapeutics, Inc.
Aug 1, 2025
Tax Payment(F)
Direct
20.1K shares at avg. $1.74$35K
AURX
Nuo Therapeutics, Inc.
Dec 31, 2018
Exercise(M)
Option to purchase common stock
Direct
50K shares-
AURX
Nuo Therapeutics, Inc.
Aug 9, 2018
Exercise(M)
Option to purchase common stock
Direct
87.5K shares-

		Type	Shares	Price		Ownership
Jun 29, 2026	AURX Nuo Therapeutics, Inc.	Award(A) Option to Purchase Common Stock	30,000	-	-	Direct
Dec 9, 2025	AURX Nuo Therapeutics, Inc.	Exercise(M)	50,000	$0.40	$20,000	Direct
Dec 9, 2025	AURX Nuo Therapeutics, Inc.	Tax Payment(F)	9,091	$2.20	$20,000	Direct
Aug 1, 2025	AURX Nuo Therapeutics, Inc.	Exercise(M)	87,500	$0.40	$35,000	Direct
Aug 1, 2025	AURX Nuo Therapeutics, Inc.	Tax Payment(F)	20,115	$1.74	$35,000	Direct
Dec 31, 2018	AURX Nuo Therapeutics, Inc.	Exercise(M) Option to purchase common stock	50,000	-	-	Direct
Aug 9, 2018	AURX Nuo Therapeutics, Inc.	Exercise(M) Option to purchase common stock	87,500	-	-	Direct

1-7 of 7 transactions

About Mintz Paul

Mintz Paul (SEC CIK 0001480208) files insider reports with the SEC as Director of Nuo Therapeutics, Inc. (AURX).

Signal8 holds 4 ownership filings by Mintz Paul, all Form 4s, filed between Aug 4, 2025 and Jul 2, 2026. Those filings report 7 transactions, from Aug 9, 2018 to Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mintz Paul's filings is in HOUSTON, TX.

Recent filings by Mintz Paul

Jun 29, 2026: Grant or award of AURX derivative securities (Form 4, code A).
Dec 9, 2025: Option exercise of AURX shares (Form 4, code M).
Dec 9, 2025: Tax withholding of AURX shares (Form 4, code F).
Aug 1, 2025: Option exercise of AURX shares (Form 4, code M).
Aug 1, 2025: Tax withholding of AURX shares (Form 4, code F).

Other insiders filing for Nuo Therapeutics, Inc. (AURX)

Pittman Scott M., Director
JORDEN DAVID EMERSON, CEO/CFO
CLAUSEN PETER, CSO/COO
WINZER C ERIC, Director
SHEEDY CHARLES E, 10% Owner

How to read Form 4 transaction codes